Study refusal and exclusion from a randomized treatment study of generalized social phobia
Study refusal and exclusion from a randomized treatment study of generalized social phobia
复制标题
DOI：
10.1016/s0887-6185(02)00238-4
复制
发表时间：
2003-01-01
影响因子：
10.3
通讯作者：
Davidson, JRT
中科院分区：
文献类型：
--
作者：
Huppert, JD;Franklin, ME;Davidson, JRT
我们检查治疗排斥率和拒绝率，以及不参与电话访谈的子样本的原因，以确定是否有资格参加广泛性社交恐惧症(GSP)治疗的随机研究。这项研究比较了团体综合认知行为疗法(CCBT)与氟西汀(Flu)、安慰剂(PLA)或它们的组合。结果表明，这项研究的主要排除原因是共病抑郁，其次是以不同的诊断为主要原因。患者拒绝进入研究也很常见，最常见的原因是不想服药。值得注意的是，拒绝加入CCBT或解放军的人很少表示反对。这些结果表明，有必要开发和评估一种治疗社交焦虑合并抑郁的方法，并系统地研究GSP患者不愿服药的原因。(C)2002 Elsevier Inc.保留所有权利。
We examine treatment exclusion and refusal rates as well as reasons for non-participation in a sub-sample of phone interviews conducted to determine eligibility for a randomized stud, of treatments for generalized social phobia (GSP). This study compared group comprehensive cognitive behavioral therapy (CCBT) to fluoxetine (FLU), placebo (PLA), or their combination. Results suggest that the major exclusion for the study was due to comorbid depression, followed by having a different diagnosis as primary. Patient refusal to enter the study was also common, with the most frequently reported reason being not wanting to take medication. Notably, few people who refused stated an objection to entering CCBT or PLA. These results suggest that there is a need to develop and evaluate a treatment for social anxiety with comorbid depression and to systematically study reasons for reluctance to take medication among individuals with GSP. (C) 2002 Elsevier Inc. All rights reserved.